# Sanli Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sanli-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Anshun, China
- Website: www.gz-sanli.com
- Total disclosed funding: $1.7M
- Latest round: Series A (Nov 14, 2014)
- Investors on record: 1

## About

Based in Guizhou, China and established in 1995, Sanli Pharmaceuticals is a medicine pharmaceutical companies that focuses on the research, development, manufacture and marketing of Chinese herbal drugs. In April 2020, Sanli Pharmaceuticals raised RMB 299.44 million in an IPO, sellings 40.74 million shares at RMB 7.35 per share on the Shanghai Stock Exchange. The company was awarded as national high-tech enterprise.

The products of the company can be categorized into seven categories which are pediatrics, respiratory medicine, cardiovascular and cerebrovascular, bonesetter, rehabilitation, ophthalmology and gastroenterology. Products within include Kai throat spray, Ziheche capsule, Sanqi capsule, Huoxiang Zhengqi capsule, Naoliqing capsule, etc.

## Funding rounds

- Series A, Nov 14, 2014, $1.7M — Guiyang Venture Capital

## Investors

- Guiyang Venture Capital (https://capitalatlas.ai/funds/guiyang-venture-capital) — Series A